Feedback / Questions
Ajovy (fremanezumab-vfrm) - Teva
Ajovy: "Global revenues of $139 million in Q1'25, +26% YoY"
(Teva)
-
May 8, 2025 -
Q1 2025 Results
Commercial
•
Migraine
https://s24.q4cdn.com/720828402/files/doc_financials/2025/q1/Q1_2025_Earnings_presentation_v6FF.pdf
May 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious